Published in:
Open Access
01-12-2019 | Insulins | Commentary
Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently)
Authors:
Davide Maggi, Fabrizio Montecucco, Gianfranco Adami, Renzo Cordera
Published in:
Diabetology & Metabolic Syndrome
|
Issue 1/2019
Login to get access
Abstract
Despite intensive research, therapy of diabetes mellitus type 2 (T2DM) is far from be effective. The most important unresolved issue is to establish a safe glycosylated hemoglobin C (A1c) value well balanced between benefit and side effects. As a result different guidelines suggest different A1c targets generating confusion for patients and clinicians. Here we report two observations which might support a relaxed A1c as suggested by American college of physician (ACP).